News | Conquer Cancer, the ASCO Foundation

Journalist Craig Melvin and Conquer Cancer researcher Kimmie Ng, MD, MPH, discuss the troubling increase of young-onset colorectal cancer and advocate for screening and awareness.

When the U.S. Preventive Services Task Force released its draft guidance to lower the colon cancer screening age from 50 to 45 in November 2020, Craig Melvin was on the story.

Conquer Cancer, the ASCO Foundation, is celebrating the life of Marc Citron, MD. Dr. Citron was a research pioneer and Conquer Cancer donor, who died February 25, 2020, from recurrent glioblastoma. He was 72.

Researchers from The University of Texas MD Anderson Cancer Center published a study in Nature Medicine showing promising results for patients with non-small cell lung cancer (NSCLC).

Stephen A. Cannistra, MD, FASCO, was among the first scientists to define the mechanisms by which ovarian cancer cells spread throughout the peritoneal cavity. His work further defined the role of apoptosis in mediating chemotherapy-induced killing of ovarian cancer cells, as well as the possibility of using gene expression arrays to predict chemotherapy responsiveness in this disease. In the clinic, he was one of the first to show that the anti-angiogenic agent bevacizumab was active in patients with recurrent disease, paving the way for using this drug in the first-line setting.